- Home
- INKT vs JAGU Comparison
INKT vs JAGU Comparison
Compare INKT & JAGU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$10.93
Company Overview
Basic Information| Metric | INKT | JAGU |
|---|---|---|
| Founded | 2017 | 2022 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.6M | 63.2M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | INKT | JAGU |
|---|---|---|
| Price | $10.93 | $2.64 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | 5.3K | ★ 430.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.66 | $2.26 |
| 52 Week High | $76.00 | $3.60 |
Technical Indicators
Market Signals| Indicator | INKT | JAGU |
|---|---|---|
| Relative Strength Index (RSI) | 37.06 | 40.60 |
| Support Level | $6.85 | $2.32 |
| Resistance Level | $11.65 | $3.38 |
| Average True Range (ATR) | 0.31 | 0.52 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 4.25 | 37.69 |
Price Performance
Historical Comparison INKT
JAGU
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.